Julian Baker, Director at IGM Biosciences, Inc. (IGMS), bought 5,625,000 shares at $8.00 ($45.0M) on 2023-06-26, disclosed to the SEC on 2023-06-28.
Open-market purchase of $45.0M IGMS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 413,175 | $3.3M | 7.3% |
| 2 | $8.00 | 5,211,825 | $41.7M | 92.7% |
| Total | $8.00 avg | 5,625,000 | $45.0M | 100% |
| Filing → |
| MDGL | BUY | 2023-11-15 | $15.6M | — | Filing → |
| BCEL | SELL | 2023-10-23 | $211K | — | Filing → |
| INCY | BUY | 2022-02-14 | $213.5M | — | Filing → |